Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Australia's MDEC (medical device evaluation committee) backs training, seeks clarity on DEHP (di(2-ethylhexyl)phthalate)

This article was originally published in Clinica

Executive Summary

The Australian medical device evaluation committee (MDEC) has endorsed proposals put forward by the therapeutic goods administration for the training of surgeons in the use of medical devices. It has also welcomed the TGA's offer to work with manufacturers and sponsors to recommend appropriate training for staff in handling devices.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT057781

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel